Published in Gene Therapy Weekly, July 27th, 2006
"RNA interference (RNAi) represents a powerful method for specific gene silencing. It is mediated through small double-stranded RNA molecules (siRNAs) which sequence-specifically trigger the cleavage and subsequent degradation of their target mRNA," wrote S. Werth and colleagues, University of Marburg.
They continued, "One critical factor that determines the success of RNAi is the ability to deliver intact siRNAs into...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-07-27)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.